New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October...( PARSIPPANY N.J. Sept. 19 /- Over ...)

PARSIPPANY, N.J., Sept. 19 /PRNewswire/ -- Over 20 new speakers will grace the faculty of the "Pharma & Biotech Competitive Intelligence & Business Analysis" conference in two weeks in New Jersey. The conference is the gold standard for pharmaceutical CI, Business Analysis, and Market Forecasting executives; 200 from the top 25 companies will gather on October 1-2 to attend the meeting. Competition has never been fiercer to launch successful products and monitor competitor moves in crowded therapeutic classes. This year's show brings together an unprecedented gathering of speakers and attendees from around the industry.

Among the many new speakers the audience will have opportunity to hear from are:

-- Bill Sammon

Senior Director of Strategy Information Analysis

Pfizer

-- David Stefanoni

Director, Business Intelligence; Business Excellent, Analytics &

Planning

Sanofi-Aventis

-- David Kamenir

Associate Director, Strategic Brand & Competitor Insights

Novo Nordisk

-- Ian Malcolm

Vice President Strategic Marketing

Exelixis

-- Susanne Laningham

Director Business Analysis & Information

Amgen

-- Thomas Han

Director, Strategic Marketing

Biovail

-- J J Owen

Associate Director, Scientific & Competitor Analysis

Millennium

-- Joshua Owolabi

Assistant Director, Discovery & Assessment Group

TAP Pharmaceuticals

-- Renee Pierson

Director

Ortho McNeil Pharmaceutical

The conference and exhibition will take place in Parsippany, NJ and is the only annual conference featuring 90% pharmaceutical company speakers for just the life sciences industry, reports Mark Alexay of Apaporis, the organizer. 35 pharmaceutical company speakers are featured this year; the attendee list is posted at